Antibiotic Therapy for Patients with Diarrhea

Introduction to Antibiotic Use

• For most patients with acute watery diarrhea without recent international travel, empiric antimicrobial therapy is not recommended as the condition is typically self-limiting 1, 2

When to Consider Antibiotics

• Antibiotics are generally not recommended for immunocompetent children and adults with bloody diarrhea while awaiting diagnostic results 1, 3
• Exceptions include infants <3 months of age with suspected bacterial etiology 1, 4
• Immunocompetent patients with documented fever, abdominal pain, bloody diarrhea, and bacillary dysentery presumptively due to Shigella should be treated with antibiotics 1, 3
• Recent international travelers with temperatures ≥38.5°C and/or signs of sepsis should receive empiric antibiotic therapy 1, 2
• Immunocompromised patients with severe illness and bloody diarrhea should be treated with antibiotics 2, 5

Antibiotic Selection

• For adults, first-line options include fluoroquinolones or azithromycin, depending on local susceptibility patterns and travel history 1, 6
• For children, first-line options include third-generation cephalosporin for infants <3 months or those with neurologic involvement 6, 2
• For children, azithromycin can be used based on local susceptibility patterns and travel history 6

Special Considerations

• Enteric fever should be treated empirically with broad-spectrum antibiotics after collecting blood, stool, and urine cultures; narrow therapy once susceptibility results are available 1, 7
• Asymptomatic contacts of patients with diarrhea should not receive empiric antibiotics 1, 8
• Modify or discontinue antibiotics when a specific pathogen is identified 1, 6
• Consider non-infectious causes in patients with symptoms lasting ≥14 days 2, 3
• The primary treatment for most infectious diarrhea is adequate rehydration with oral rehydration solution (ORS) 1, 8
• Antimotility agents like loperamide can be considered in adults once adequately hydrated but should not be given to children <18 years 7

Monitoring and Follow-up

• Reassess fluid and electrolyte balance, nutritional status, and antibiotic efficacy in patients with persistent symptoms 2, 3
• Clinical and laboratory reevaluation may be needed for non-responders 2, 3
• Follow-up stool testing is generally not recommended after symptom resolution except in certain situations required by local health authorities 3, 4

Antibiotic Treatment for Infectious Diarrhea

Critical Considerations for Antibiotic Use

• The Infectious Diseases Society of America recommends that antimicrobial agents administered to patients with Shiga toxin-producing E. coli (STEC) infections may increase the risk of hemolytic uremic syndrome (HUS), a potentially life-threatening complication where antibiotics worsen outcomes rather than improve them 9, 10
• The choice between fluoroquinolones and azithromycin as first-line options depends critically on regional resistance patterns, as resistance to fluoroquinolones has emerged in many areas 10
• Antimotility agents, such as loperamide, should NOT be given to children <18 years of age with acute diarrhea, and should be avoided in suspected or proven inflammatory diarrhea or diarrhea with fever due to risk of toxic megacolon 11
• Treatment of salmonellosis with antibiotics, including quinolones, can prolong the carrier state and increase clinical relapse rates, and recent antimicrobial use increases susceptibility to resistant Salmonella infections 10
• The use of metronidazole or vancomycin for C. difficile enhances colonization with vancomycin-resistant enterococci 10
• Isotonic intravenous fluids, such as lactated Ringer's or normal saline, should be administered for severe dehydration, shock, altered mental status, or oral rehydration solution (ORS) failure, and human milk feeding should continue throughout the diarrheal episode in infants and children 11
• Good antibiotic stewardship is a key strategy to decrease rates of C. difficile infection and prevent emergence of resistant strains, and the shift away from empiric antibiotics for most infectious diarrhea reflects the recognition that inappropriate antibiotic use causes more harm than benefit through adverse effects, resistance development, and worsening of certain infections like STEC and C. difficile 9, 10
• Critical warning: Antimotility agents and certain antibiotics can worsen C. difficile outcomes, potentially leading to severe complications including death 9, 12